OS Therapies Inc. has entered into agreements to encourage investors to exercise warrants for 5,382,148 shares at a reduced price of $1.40 each, resulting in an expected $7.5 million in proceeds for regulatory efforts and corporate needs; the event is noted to have occurred on January 10, 2026.